APP

APP (amyloid beta precursor protein; HGNC:620, NCBI Gene 351) is the gene on chromosome 21q21.3 encoding the amyloid precursor protein — a ubiquitous transmembrane protein whose sequential cleavage by β- and γ-secretases releases the amyloid-β peptide (Aβ40/Aβ42) that aggregates into the plaques of Alzheimer's disease. Its duplications and missense mutations cause familial early-onset Alzheimer's, and trisomy 21's extra copy explains the Alzheimer pathology that people with Down syndrome develop by middle age — the gene-dosage proof of the amyloid cascade.

Approved Symbol
APP (HGNC:620)
Chromosomal Locus
21q21.3
Encoded Product
APP — a 110–130-kDa single-pass transmembrane glycoprotein (695–770 aa isoforms)
Primary Pathway
β-secretase → γ-secretase cleavage → Aβ42 aggregation (amyloid cascade)
Clinical / Therapeutic Role
Familial Alzheimer's (duplications, Swedish/Arctic mutations); anti-amyloid therapy's target

Gene Structure & Expression

Molecular Function & Pathways

Clinical & Therapeutic Significance

Interacting Systems & Components

Sources

HGNC Gene Record

Approved Symbol
APP
Approved Name
amyloid beta precursor protein
Chromosomal Locus
21q21.3
HGNC Authority
HGNC:620